MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 18:31:34 02/09/2026 BST			5-day change	1st Jan Change
552.70 ^USD	+0.92%		+1.10%	+22.04%

03:00pm	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 10:47 am
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 02:35 pm
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 10:20 am